GM03163
LCL from B-Lymphocyte
Description:
HLA HISTOCOMPATIBILITY TYPE: 142800 THROUGH 142860 & 142880
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
| |
| HLA TYPING |
HLA type; A:30; B:13; C:w6; DR:7 |
| |
| Remarks |
HLA type; A:30,B:13,C:w6,DR:7 line LBF; consanguineous parents; DP typed negative for DP 1 through 6 |
| Woulfe SL, Bono CP, Zacheis ML, Welply JK, Kirschmann DA, Baudino TA, Wang Y, Stone DA, Hanson GJ, Vuletich JL, Bedell LJ, Schwartz BD, Howard SC, A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation. J Pharmacol Exp Ther281:663-9 1997 |
| PubMed ID: 9152371 |
| |
| Giles RC, DeMars R, Chang CC, Capra JD, Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion. Proc Natl Acad Sci U S A82:1776-80 1985 |
| PubMed ID: 3856859 |
| |
| Walker LE, Ketler TA, Houghten RA, Schulz G, Chersi A, Reisfeld RA, Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site. Proc Natl Acad Sci U S A82:539-42 1985 |
| PubMed ID: 3881768 |
| |
| Charron DJ, Lotteau V, Turmel P, Hybrid HLA-DC antigens provide molecular evidence for gene trans- complementation. Nature312:157-9 1984 |
| PubMed ID: 6209579 |
| |
| Kuo MC, Li XM, Marti GE, Sachs JA, Sogn JA, Coligan JE, Kindt TJ, Primary structural sequence polymorphism in the human class II MHC antigen 33.1. Immunogenetics19:27-37 1984 |
| PubMed ID: 6319275 |
| |
| Goyert SM, Silver J, Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. Proc Natl Acad Sci U S A80:5719-23 1983 |
| PubMed ID: 6193521 |
| |
| Goyert SM, Shively JE, Silver J, Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J Exp Med156:550-66 1982 |
| PubMed ID: 6808075 |
| |
| Quaranta V, Walker LE, Ruberto G, Pellegrino MA, Ferrone S, The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28. Immunogenetics13:285-95 1981 |
| PubMed ID: 6168579 |
| |
| Quaranta V, Walker LE, Pellegrino MA, Ferrone S, Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J Immunol125:1421-5 1980 |
| PubMed ID: 6157732 |
| dbSNP |
dbSNP ID: 10614 |
| Gene Cards |
HLA-A |
|
HLA-DPA1 |
|
HLA-DRA |
| Gene Ontology |
GO:0005887 integral to plasma membrane |
|
GO:0006955 immune response |
|
GO:0019883 antigen presentation, endogenous antigen |
|
GO:0019884 antigen presentation, exogenous antigen |
|
GO:0019885 antigen processing, endogenous antigen via MHC class I |
|
GO:0019886 antigen processing, exogenous antigen via MHC class II |
|
GO:0030106 MHC class I receptor activity |
|
GO:0045012 MHC class II receptor activity |
| NCBI Gene |
Gene ID:3105 |
|
Gene ID:3113 |
|
Gene ID:3122 |
| NCBI GTR |
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A |
|
142860 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA |
|
142880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1 |
| OMIM |
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A |
|
142860 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA |
|
142880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1 |
| Omim Description |
HLA-A HISTOCOMPATIBILITY TYPE |
| |
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A |
| |
HLA-DR HISTOCOMPATIBILITY TYPE; HLA-DRA |
| |
MAJOR HISTOCOMPATIBILITY COMPLEX II, DR ALPHA; HLA-DRA1 |
| |
HLA-SB HISTOCOMPATIBILITY TYPE; HLASB; HLADP |
| |
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1 |
| Split Ratio |
1:4 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|